bRIGHT 2-year real-world outcomes, presented by R. Bekeredjian
bRIGHT results support the exceptional safety and effectiveness of TriClip TEER in real-world population at 2 years
LEARN MORE:
Related Resources
Poster: Primary MR in the Very Elderly
TRILUMINATE Pivotal - 2-year update EuroPCR 25
Prognosis of TR after MitraClip for MR
PCR LV 2021: Navitor™ 30-day outcomes
Data Summary PFO closure in patients > 60 Years
PCR LV 2021: Navitor™ Looking ahead
ACC 2023: COAPT™ trial
ESOC presentation: PFO closure in patients > 60 Years
TRENDING TOPICS
Prognosis of TR after MitraClip for MR
Poster: Primary MR in the Very Elderly
TRILUMINATE Pivotal - 2-year update EuroPCR 25
